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Neurological disease associated with HIV infection results from either primary replication of the virus or a combination of
virus infection and replication of opportunistic pathogens in the CNS. Recent studies indicate that the primary infection is
mediated mainly by viruses that utilize CCR5 as the coreceptor; it is not known whether the syndrome can be mediated by
viruses that use the CXCR4 coreceptor. The macaque model of the disease using simian immunodeficiency virus (SIV) has
confirmed that CCR5-using viruses such as SIVmac251 can cause primary disease in the CNS. In this report we have examined
the role of simian–human immunodeficiency virus (SHIV)KU-2, a CXCR4 virus which replicates productively in rhesus
macrophages, in causing CNS disease. A survey of archival brain tissues from SHIVKU-2-infected rhesus and pig-tailed
macaques that succumbed to AIDS showed productive viral replication in the CNS of 10 of 14 rhesus animals. Eight of these
10 had additional infections with opportunistic pathogens. In contrast, 21 of 22 pig-tailed macaques had no evidence of
productive viral infection in the brain. In an earlier study we had shown that inoculation of SHIV-infected rhesus macaques
with eggs of Schistosoma mansoni, a potent inducer of IL-4, resulted in enhanced replication of the virus in tissue
macrophages. In the present study, we compared the replication of the virus in macrophages from normal rhesus and
pig-tailed macaques and determined further whether exogenous IL-4 could cause enhancement of virus replication in these
cells. These studies showed that the virus replicated productively in rhesus macrophages, and this was enhanced
significantly after recombinant macaque IL-4 was added to the medium. IL-4 also caused enhancement of virus production
in macrophages isolated from virus-infected animals. In contrast, the virus replicated only minimally in pig-tailed macaque
macrophages and supplemental IL-4 had negligible effects. The data thus suggested that failure of pig-tailed macaques to
develop encephalitis was due to the innate resistance of macrophages from this species of macaque to support replication
of SHIVKU-2. The ability of the virus to replicate in the brains of rhesus macaques was dependent on coinfection in the brain
with opportunistic pathogens which presumably induced both macrophages and IL-4 in the CNS microenvironment. AINTRODUCTION
It is well established now that the pathogenesis of HIV
infection and the complex disease patterns caused by
the virus revolve around the dystrophic effects of the
infection first, on CD4 T cells and then later, on cells of
the macrophage lineages (Rosenberg and Fauci, 1991;
Pantaleo et al., 1993; Ho et al., 1995). The first part of the
pathogenesis is focused on the highly productive infec-
tion in, and elimination of, the CD4 T cell population, the
process that leads to loss of the ability of the individual
to mount cell-mediated immune responses and to pro-
duce Th-1 cytokines such as IL-2 and IFN- (Dalgleish,
1995). The lack of these responses is associated with
two phenomena: first, development of tumors and prolif-
eration of opportunistic pathogens in different organ sys-© 2002 Elsevier Science (USA)
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54tems of the body (Barker, 1995; Orenstein et al., 1997; Liu
et al., 1999), and second, virus replication in specific
tissues such as the brain (Gendelman et al., 1994; Oren-
stein et al., 1997; Igarashi et al., 2001). Unlike other viral
infections in the brain, HIV-1 infection in the CNS is
centered around virus replication almost exclusively in
cells of macrophage lineage (Gendelman et al., 1994),
with productive replication in these cells correlating with
development of encephalitis and dementia. One of the
paradoxes of HIV dementia is that the virus invades the
brain early in infection (Ho et al., 1989) but neurological
disease develops only as a late complication of the
infection (Price et al., 1991), probably as a result of the
triggering of massive viral replication in the macrophage
population in the brain.
The macaque model of HIV infection has been used
widely to study the relationship between infection insupportive role for IL-4 in the CNS disease was suggested
macaques and reduced levels of this cytokine in the brains
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brain macrophages and neuropathogenesis. Studies on
Simian immunodeficiency virus (SIV) infection in ma-by the
from
on
caques have shown that in all cases of encephalopathy,
virus replication in macrophages in brain (identified by in
situ hybridization and immunohistochemistry) correlated
with the ability of the virus to replicate productively in
cultured macrophages derived from peripheral blood of
animals of the affected species. Examples of these are
SIV/17E-Fr (Zink et al., 1997) and SIVsmmFGb infection in
pig-tailed macaques (Novembre et al., 1998). Use of this
virus confirmed that the potential for causing encephali-
tis required competence of the virus for replicating in
activated CD4 T cells and in macrophages, with viruses
lacking tropism for macrophages being incapable of
causing encephalitis (Sharma et al., 1992; Lackner et al.,
1994). These viruses all utilize CCR5 coreceptor for entry
into susceptible cells, but it is of interest that other
CCR5-utilizing strains of SIV that were incapable of caus-
ing encephalopathy were also incapable of replicating
productively in peripheral blood mononuclear cell
(PBMC)-derived macrophages (Stephens et al., 1997).
The animals infected with SIVmac239 had viral DNA in
the brain but had no evidence of virus replication or any
pathological changes (Zhu et al., 1995).
Pathogenic simian–human immunodeficiency viruses
(SHIVs), bearing the env of HIV-1 on a background of
SIVmac239, have added a new perspective to the viral
encephalopathy. In particular, SHIVKU-2, whose env was
derived from CXCR4-utilizing HIV-HxB2, also utilizes R4
for entry into macaque cells (Hoffman et al., 1998), yet it
is macrophage-tropic in rhesus cells (Stephens et al.,
1997). Further examination of archival tissues from ma-
caques infected with this virus showed that of the 14
infected rhesus macaques that developed AIDS, 10 had
neuropathological changes with clear evidence of virus
replication in macrophages in the brain. In contrast, of 22
infected pig-tailed macaques that developed AIDS, 21
had no evidence of SHIVKU-2 replication in the brain. This
difference in susceptibility to CNS disease caused by
SHIVKU-2 in the two macaque species provided a novel
system to further explore mechanisms of lentiviral neu-
ropathogenesis.
RESULTS
A survey of pig-tailed and rhesus macaques infected
with SHIVKU-2 in our laboratory during the past 3 years
showed that animals of both species succumbed to AIDS
(Joag et al., 1996, 1997a, 1998). Most of the animals from
both species developed infectious pleocytosis in the
acute phase of infection. Affected animals had severe
loss of CD4 T cells, extremely high titers of viral RNA in
blood and lymphoid tissues, and various opportunistic
infections. However, whereas 10 of 14 rhesus macaques
with AIDS had encephalitis, only 4 of 22 pig-tailed ma-
caques with AIDS developed neurologic disease (Table
1). All of the 10 rhesus macaques with encephalitis also
had evidence of productive SHIV replication in the brain.
Eight of these had concurrent infections by opportunistic
pathogens. In contrast, among 4 of the 22 pig-tailed
animals that developed encephalitis, 3 had opportunistic
infections, but no productive replication of SHIV. One of
the 4 had focal encephalitis that appeared to be associ-
ated with SHIV infection since viral antigen was found in
these foci. Thus, only 1 of 22 pig-tailed macaques had
productive SHIV infection in brain. Among the animals
that failed to develop encephalitis (4 rhesus and 18
pig-tailed), all of the brain regions from rhesus macaques
were positive for viral DNA, while fewer brain regions
were positive for viral DNA in the pig-tailed animals. The
presence of viral DNA was monitored in 3 animals of
each species that were infected with the virus. Figure 1
demonstrates the pattern of viral DNA expression in
brain tissues from one such representative each of rhe-
sus and pig-tailed macaque. There was, however, no
evidence of viral replication, as demonstrated by in situ
hybridization, immunocytochemistry, or infectivity in tis-
sue homogenates (data not shown). Thus, whereas both
rhesus and pig-tailed macaques were susceptible to
development of AIDS following inoculation with highly
pathogenic SHIVKU-2, the two species of animals varied
greatly in development of neurological complications as-
sociated with replication of the virus in the CNS.
TABLE 1
CNS Lesions and Associated Etiologic Agents in Rhesus (Rh) and
Pig-Tailed (Pt) Macaques Infected with SHIVKU-2
Animal Neuropathologya SHIV RNAb
Opportunistic
agent
40K-Pt LE  NDc
40M-Pt LE  SV40
24C-Pt LE  SV40
18A-Pt EM  Toxoplasma
16A-Rh EM  SV40, CMV
16B-Rh LE  SV40
16C-Rh LE  SV40
39A-Rh LEM  NDc
44O-Rh LE  NDc
16D-Rh LE & GS  CMV
23A-Rh LE & GS  CMV
39E-Rh MEM  CMV
44N-Rh ME  CMV
23D-Rh LE  SV40
Note. SHIVKU-2-infected rhesus macaques demonstrated neuropa-
thologies associated with opportunistic agents and SHIVKU-2 (10 of 14),
whereas infected pig-tailed macaques exhibited neuropathology asso-
ciated exclusively with opportunistic pathogens and not SHIVKU-2 (21 of
22).
a LE, leukoencephalitis; EM, encephalomyelitis; LEM, leukoencepha-
lomyelitis; GS, ganglionitis; MEM, meningoencephalomyelitis; ME, me-
ningoencephalitis.
b SHIV RNA was determined by in situ hybridization. () denotes
presence of viral RNA and () denotes absence of viral RNA.
c ND, not detected.
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In the present study, since the cells of macrophage
lineage appear to contribute to the development of HIV
encephalitis, we asked whether the pathological
changes were associated with permissiveness of the
PBMC-derived macrophages from the two species to
support replication of the virus. Macrophages were iso-
lated from three animals of both species, inoculated with
the virus, and assessed for the presence of viral p27. As
seen in Fig. 2A, PBMC-derived macrophage cultures
from normal rhesus macaques developed productive in-
fection, following inoculation with the virus. However,
macrophages from normal pig-tailed macaques inocu-
lated with SHIVKU-2 either failed to produce or were only
minimally productive for viral p27 (Fig. 2C). These data
correlated with pathogenesis.
Earlier studies by Valentin et al. (1998) had shown that
IL-4 had a major enhancing effect on transcription of HIV
RNA in human macrophage cultures. We therefore asked
whether SHIVKU-2 replication in macrophages would be
affected by treatment with exogenous recombinant ma-
caque (rm)IL-4. This study was performed in two types of
macrophage cultures: (a) cultures derived from normal
animals and inoculated with the virus in culture and (b)
cultures derived from infected macaques and examined
directly for production of virus. Examination of cultures
from normal animals inoculated with similar multiplicities
and then treated with as little as 1.5 U of rmIL-4 per
milliliter resulted in an enhancement of viral replication.
Figure 2 shows that rmIL-4-treated cultures had an in-
creased number of cells expressing viral antigen (Figs.
2B and 2D) compared to untreated infected cultures
(Figs. 2A and 2C) and this increase coincided with ele-
vation in viral reverse transcriptase levels (Fig. 3A), sug-
gesting that IL-4 potentiated a spreading, productive
infection among the cells. In comparison to rhesus mac-
rophages, pig-tailed macrophages were much less per-
missive to SHIVKU-2 infection, although, similar to rhesus
macrophages, viral replication in macrophages from pig-
tailed macaques also increased after treatment with IL-4,
albeit only slightly (Fig. 3B). The specificity of the IL-4
effect was confirmed by treatment of infected rhesus
macrophage cultures with anti-IL-4 antibody. This re-
sulted in a decrease in viral replication (Fig. 3A). Exam-
ination of cultured macrophages from SHIVKU-2-infected
macaques of both species showed the same effect.
Again, fewer numbers of macrophages derived from PB-
MCs of infected pig-tailed macaques produced viral an-
tigen than those from infected rhesus macaques (Figs.
2E and 2G). Further, the replication of virus in macro-
phage cultures from infected rhesus macaques was en-
hanced after treatment with rmIL-4 (Figs. 2F and 2H).
Since IL-4 had an enhancing effect on SHIVKU replica-
tion in cultured macaque macrophages, we next en-
quired whether rhesus and pig-tailed macaques differed
in their abilities to produce IL-4 and whether this ability
was affected by the highly productive SHIVKU infection in
their lymphoid systems. In an initial study, PBMCs from
three animals of both species were stimulated with
staphylococcal enteroxin A (SEA) and examined for the
presence of cytokine RNA. These studies showed that
mitogen-stimulated PBMCs from uninfected animals of
both species produced both Th-1 (IFN- and IL-2) and
Th-2 (IL-4 and IL-10) cytokines indistinguishably (data not
shown). However, similar treatment of PBMCs from in-
fected pig-tailed animals showed that mitogen-stimu-
lated PBMCs from these macaques lacked Th2 cytokines
IL-4 and IL-10. In contrast, both of the Th2 cytokines were
present in activated PBMCs from infected rhesus ma-
caques (Table 2).
To understand whether this disparity in IL-4 production
by the macaques of both species was also reflected in
IL-4 production in the brains of these animals, we exam-
ined four regions of brain from three rhesus and three
pig-tailed animals infected with SHIVKU for evidence of
IL-4 expression. Figure 4 demonstrates the results from
one representative animal from each species. Most of
the pig-tailed macaque brain extracts lacked IL-4 RNA.
While all four brain regions from the rhesus macaque
were positive for IL-4 RNA, only one of four brain regions
of the pig-tailed macaque expressed IL-4 RNA (Fig. 4).
DISCUSSION
This study using the SHIVKU model illustrated two new
aspects of neuropathogenesis of HIV infection. First, it
FIG. 1. PCR amplification of SHIV sequences from different regions of
the brain from pig-tailed (A) and rhesus (B) macaques dying of AIDS.
DNA from different brain regions from one representative animal from
each species of macaque was extracted and used in nested PCR with
oligonucleotides that amplified the gag gene of SHIVKU-2 as described
in the text. Aliquots of the nested PCR were run on a 1.5% agarose gel
and stained with ethidium bromide. DNA from three infected animals of
each species was extracted and analyzed by PCR. A representative
experiment is shown.
56 BUCH ET AL.
FIG. 2. Immunohistochemistry demonstrates that SHIVKU-2 infects macrophages from pig-tailed and rhesus macaques. Macaque macrophage
cultures were infected with SHIVKU-2 (A–D). At 7 days following inoculation, cells were washed, fixed, and stained for p27 antigen as previously
described (Raghavan et al., 1997). Cells that stain positive have a red color when compared to background. (A) Rhesus macrophages infected
in culture. (B) Rhesus macrophages infected in culture in the presence of rmIL-4. (C) Pig-tailed macrophages infected in culture. (D) Pig-tailed
macrophages infected in culture in the presence of rmIL-4. (E) Macrophage cultures from SHIVKU-2-infected rhesus macaques. (F) Macrophages
from SHIVKU-2-infected rhesus macaque treated with 1.5 U/ml of rmIL-4. (G) Macrophage cultures from SHIVKU-2-infected pig-tailed macaques.
(H) Macrophage cultures from SHIVKU-2-infected pig-tailed macaque treated with rmIL-4 showing numerous cells with viral antigen (red).
Macrophage cultures from three animals of each species were isolated and tested for the presence of viral antigen postinfection. A
representative experiment is shown.
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showed that animal hosts of different species could
recapitulate one aspect of the HIV disease complex
(development of AIDS) and vary dramatically in suscep-
tibility to another (neurovirulence). Both rhesus and pig-
tailed macaques are highly susceptible to SHIVKU-in-
duced loss of CD4 T cells, the resultant severe immu-
nosuppression, and AIDS, but only the rhesus animals
developed CNS disease with any degree of frequency.
With rare exceptions in which one pig-tailed macaque in
this study and one in another study (McCormick-Davis et
al., 2000) developed lentiviral encephalitis, animals of
this species uniformly failed to develop encephalitis after
inoculation with SHIVKU-2. However, in all cases studied,
SHIVKU-2 invaded the brain during productive infection in
the lymphoid system, but the viral life cycle did not go to
completion in the brain. Although these animals died
with AIDS and had viral DNA in the neuropil, there was
no evidence of viral proteins or lesions in the CNS. This
was associated with and probably attributable to the
poor susceptibility of pig-tailed macrophages to produc-
tive infection with the virus. This result was very similar
to the failure of SIVmac239 to cause CNS disease (Ste-
phens et al., 1997). The latter virus is R5 in coreceptor
usage but, similar to SHIVKU-2, which is an X4 virus, both
viruses failed to complete life cycles in macrophages,
one of the fundamental requirements for neuropathogen-
esis by lentiviruses. The presence of viral DNA alone in
the CNS was thus not predictive of disease. Rhesus
macaques were a clear contrast to the pig-tailed animals
in that macrophages derived from peripheral blood of
these animals were susceptible to productive infection
by SHIVKU-2. This correlated with the productive SHIV
FIG. 3. Reverse transcriptase activity in supernatants of macrophage
cultures from rhesus (A) and pig-tailed (B) macaques that were infected
with SHIVKU-2 (‚), infected with SHIVKU-2 and treated with 1.5 U/ml rmIL-4
(), and infected with SHIVKU-2 with IL-4 and 200 g/ml neutralizing IL-4
antibody (E). Macrophage cultures from three animals of each species
were infected with SHIVKU-2 and analyzed in triplicate determinations.
Error bars represent standard deviations.
TABLE 2
CD4 Counts and Cytokine Expression in SEA*-Stimulated PBMCs
from SHIVKU-2-Infected Pig-Tailed and Rhesus Macaques
Animal
CD4 T
cells/l
Th-1 cytokines Th-2 cytokines
IL-2 IFN- IL-4 IL-10
40L-Pt 70    
40M-Pt 0  ND  
42P-Pt 962    
42Q-Pt 0    
42T-Pt 1893    
42U-Pt 106    
46F-Pt 54    
46Q-Pt 180    
38W-Rh 92    
38Z-Rh 225    NDa
39F-Rh 912    
39G-Rh 781    
39H-Rh 719    
Note. PBMCs (5  106) were purified from SHIVKU-2-infected rhesus
and pig-tailed macaques and stimulated with SEA (1 g/ml). Twenty-
four hours later cells were harvested, and RNA was isolated and
assessed for the abundance of Th-1 (IL-2 and IFN-) and Th-2 (IL-4 and
IL-10) cytokine mRNAs by RT-PCR as detailed under Materials and
Methods. SEA*, superantigen; () indicates presence of the respective
cytokine band on the gel, () indicates absence of the respective
cytokine band on the gel; and () indicates a faint band on the gel.
a ND, not determined.
FIG. 4. IL-4 expression in the brain from SHIVKU-2-infected rhesus (A)
and pig-tailed (B) macaques. RT-PCR using IL-4-specific primers was
performed on equal amounts of RNA isolated from different regions of
the brain from one representative each of rhesus and pig-tailed ma-
caque. Lane 1, frontal; Lane 2, parietal; Lane 3, occipital; Lane 4,
midbrain. Aliquots of amplified products were then run on 1.5% agarose
gel and stained with ethidium bromide. Brain regions from three
SHIVKU-2-infected rhesus and pig-tailed macaques were assayed for
IL-4 expression. A representative experiment is shown.
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infection in the brain and the neuropathological changes
seen in the animals that developed CNS disease.
The second novel aspect of this study was that SHIVKU
is a classical X4 virus, having the envelope of HIV-1
(HXB2) (Li et al., 1992), yet it is not only macrophage-
tropic but also neuropathogenic, in the sense that all of
the animals that developed neurological disease follow-
ing inoculation with this virus also showed productive
infection in the brain with the virus. The major difference
between this virus and the highly neuropathogenic virus
SIVmac251 was that SHIVKU-2 was not associated with
primary disease in the CNS since nearly all of the ani-
mals (8/10) that had CNS disease also had evidence of
infections with opportunistic pathogens in the CNS. Four
of the animals dying of AIDS but presenting no neuro-
pathological changes had only viral DNA in the brain,
similar to pig-tailed animals infected with this virus (de-
scribed in this report) and rhesus animals infected with
SIVmac239, reported in an earlier communication (Zhu et
al., 1995). However, it was of interest that in an earlier
study (Buch et al., 2000) in which 5 rhesus macaques
were inoculated with SHIVKU-2, followed by examination
of 3 of the animals on days 2, 5, and 11 postinoculation,
all showed evidence of increasingly productive infection
in the CNS. The animal euthanized on day 2 postinocu-
lation had viral DNA in the brain, confirming early viral
invasion into the CNS, and by day 11, the infection had
spread to all regions of the brain. Yet, there were no
accompanying pathological changes. Two of the inocu-
lated animals examined a few months later also had no
neuropathological changes. Only viral DNA was detect-
able in the neuropil. Thus, the viral infection in the brain
that became established early during the systemic infec-
tion was not progressive in the CNS, a situation analo-
gous to the 4 animals reported in this study that failed to
develop CNS disease.
The role of IL-4 shed new light on the neuropathogen-
esis of this infection. It is clear that this cytokine was a
potent enhancer of SHIVKU-2 replication in rhesus macro-
phages. Since this cytokine and macrophages are both
induced by many opportunistic pathogens, it is strongly
suggestive that the presence of such pathogens in the
brain of SHIVKU-2-infected rhesus macaques could have
provided the double stimuli for enhancing replication of
the virus in the neuropil. Support for this concept comes
from an earlier study in which Schistosoma mansoni
eggs (powerful inducers of Th-2 cytokine response) were
inoculated into the portal vein of SHIV-infected rhesus
macaques. The animals developed granulomatous le-
sions in the liver and macrophages in the lesions
showed extensive viral replication (Buch et al., 2001). A
similar mechanism could explain the productive viral
infection in brains that had simultaneous infections with
opportunistic pathogens such as Toxoplasma gondi,
SV40, and CMV, and the failure of the viral infection to
progress in the absence of opportunists. In the case of
pig-tailed macaques, IL-4 had minimal stimulatory ef-
fects, since the virus was inherently incapable of repli-
cating productively in pig-tailed macrophages. The fail-
ure of 18 of the 22 infected pig-tailed animals to develop
SHIV-associated neurological disease could therefore
be attributed to the nonpermissive nature of the viral
infection in the macrophages. In summary, our data sug-
gest that SHIVKU-2, which is macrophage-tropic in rhesus
macaques, despite being an X4 virus, was capable of
causing infection in the CNS of these animals, but re-
quired locally produced IL-4 for maintenance of produc-
tive replication in the brain. The cytokine was presum-
ably supplied during the infection by opportunistic patho-
gens. In the absence of these infections, replication of
the virus in the brain remained at a minimal rate. In
contrast, the failure of pig-tailed animals to develop neu-
rological disease was explainable solely on the basis of
nonpermissiveness of the macrophages from these an-
imals to support replication of this virus.
The major difference in neuropathogenesis between
the X4 using SHIVKU-2 and the R5-using SIVs seems to be
that wherein the former may require a coinfection with an
opportunistic pathogen to trigger full expression of the
virus life cycle, the R5 virus may be a primary CNS
pathogen that does not require help.
MATERIALS AND METHODS
Viruses
We obtained a SHIV-4 DNA encoding the env, tat, rev,
and vpu genes of HIV-1 HXBc2 on a background of
SIVmac239 (Li et al., 1992) from Dr. Joseph Sodroski, Har-
vard University. Viral DNA was transfected into CEMx174
cells to produce a virus that was used to initiate sequen-
tial passages in macaques. Virus isolated from cerebro-
spinal fluid obtained 8 weeks postinoculation from pig-
tailed macaque PNb in passage 4 was amplified in a
culture of PBMCs from a normal macaque and subse-
quently designated SHIVKU-1 (Joag et al., 1996). A further
passage of this virus in rhesus macaques gave rise to
SHIVKU-2 (Joag et al., 1998). SHIVKU-2 was inoculated intra-
venously in all the rhesus and pig-tailed macaques in
this study.
Macaques
Pig-tailed and rhesus macaques were used in this
study. Animals were housed individually or in pairs in
American Association for Laboratory Animal Care-ac-
credited facilities at the University of Kansas Medical
Center.
Cell cultures
Cells from the human T cell line C8166 were used as
indicator cells to measure virus infectivity. PBMCs from
normal and infected macaques were obtained by Ficoll-
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Hypaque (Sigma, St. Louis, MO) gradient centrifugation.
Cells were cultured at a concentration of 106/ml in R10
medium (RPMI-1640 supplemented with 10 mM HEPES
buffer, pH 7.3, 50 g/ml gentamicin, 50 M 2-mercapto-
ethanol, and 2 mM glutamine and containing 10% heat-
inactivated fetal bovine serum) and stimulated with
staphylococcal enterotoxin A at a concentration of 1
g/ml for 24 h.
Macrophages from infected and uninfected macaques
were cultured on plastic coverslips placed in 6-well
dishes in macrophage differentiation medium (Joag et al.,
1994). After differentiation, macrophages from uninfected
animals were inoculated with cell-free SHIVKU-2 at an
m.o.i. of 0.01 for 24 h and extensively washed in R-10.
Each experiment was performed in triplicate determina-
tions. Cells were cultured for 7 days in the presence or in
the absence of rmIL-4 at a concentration of 1.5 U/ml
(Valentin et al., 1998). Viral replication was monitored by
assaying the reverse transcriptase activity in the super-
natants as described by Smith et al. (1987). Adherent
macrophages on coverslips were processed for immu-
nocytochemistry for detection of viral protein, p27
(Raghavan et al., 1997). Macrophages from infected an-
imals were treated with or without rmIL-4 for 7 days. For
blocking experiments with antibody, SHIVKU-2-infected
cells were treated with rmIL-4 and 200 ng/ml of anti-IL-4
neutralizing mAb (Pharmingen). The medium was replen-
ished every third day with fresh rmIL-4 (1.5 U/ml) and
anti-IL-4 neutralizing mAb.
Brain dissection and neuropathology
Animals were deeply anesthetized and exsanguinated
by aortic cannulation and the vasculature was perfused
with 1 liter of normal saline. Within 1 h of necropsy, the
brain and spinal cord were removed and the brain was
bisected sagitally using aseptic technique. The right half
was immediately transferred into 10% buffered formalin
and the left half was then dissected into nine anatomi-
cally distinct regions. All samples were snap-frozen over
dry ice and stored at 70°C for PCR analyses. Portions
of the left half of the brain and the entire right half were
kept in buffered formalin for 3 to 4 days. Paraffin sections
were stained with hematoxylin and eosin (H&E) as a
preliminary screen for morphological abnormalities, and
serial sections were stained with Luxol fast blue (LFB)
and Sevier Munger stains for assessment of suspected
myelin and axonal abnormalities, respectively (Raghavan
et al., 1997). For the detection of CMV, the oligonucleo-
tides used in the first round were 5-AGATTCTATAGGC-
TATATATGACGTAATGG-3 (sense) and 5-GCAGACAAA-
AGTAAGGTGTTGTATGCC-3 (antisense) based on the
sequence of the rhesus CMV immediate-early gene (Rh-
CMV-IE) (Alcendor et al., 1993). One microliter of the above
PCR product was used in the nested PCR under the same
reaction conditions using the primers 5-ATGCATGC-
TATATATGGGAGGAGG-3 (sense) and 5-GAATAGCGT-
CACCACTTGGCAAGGG-3 (antisense), which yielded a
248-bp product. For the detection of SV40 virus, the oligo-
nucleotides used in the first round were 5-ATGGGTGCT-
GCTTTAACACTGTTGGG-3 (sense) and 5-AGCCATTCCT-
GGTTGTTGATATAAAA-3 (antisense) based on the se-
quence of the rhesus SV40P1 gene (Flers and Ysebaert,
1978). One microliter of the above PCR product was used in
a nested PCR under the same reaction conditions using the
primers 5-CCTAATTGCTACTGTGTCTGAAGCTGC-3 (sense)
and 5-GTAGAAACTTTGTGATCCCAGTCACTA-3 (antisense),
which yielded a 250-bp product. To confirm the specificity of
the PCR products, Southern blots using 32P-labeled Rh-
CMV-IE and SV40P1 sequences, respectively, were per-
formed. The presence of Toxoplasma was determined by
histopathology.
PCR amplification
Two rounds of PCR amplification, using nested prim-
ers, were used to detect HIV env sequences in frozen
brain regions as described previously (McCormick-Davis
et al., 1998).
Detection and amplification of cytokine mRNA
RNA from SEA-stimulated PBMCs and weighed brain
tissue portions was isolated in Trizol reagent (Life Tech-
nologies, Gaithersburg, MD) followed by precipitation
with isopropanol. Air-dried RNA pellets were then resus-
pended in distilled water and their concentrations deter-
mined spectrophotometrically. The quality of RNAs was
assessed by RT-PCR for the cellular gene GAPDH mRNA
as described (Smith et al., 1987) using the Titan One-
Tube RT-PCR System (Boehringer Mannheim, Indianap-
olis, IN). DNA contamination in the RNA preparations
was assessed by carrying out duplicate reactions and
subjecting one of them to 99°C for 2 min followed by 3
min at 95°C, to inactivate the RT activity. If necessary,
DNA was removed with DNase I (Life Technologies),
followed by extraction. One microgram of total RNA from
each sample was used in the one-step reaction contain-
ing the manufacturer’s buffer and enzyme mix, appropri-
ate primers, and 1.6 U Prime RNase inhibitor (5 Prime3
3 Prime, Inc., Boulder, CO). The reactions were carried
out in a Perkin–Elmer DNA A Thermal Cycler 480 with a
temperature profile of 42°C for 30 min for 1 cycle; 94°C
for 5 min for 1 cycle; 94°C for 30 s, 55°C for 30 s, 68°C
for 45 s for 10 cycles; 94°C for 30 s, 55°C for 30 s, 68°C
for 45 s, 5 s of extension/cycle, for 25 cycles; 68°C for 6
min. Nine microliters of the amplification products was
fractionated by electrophoresis through agarose/TAE
gels and visualized with ethidium bromide staining. The
sequences of primers specific for amplification of
GAPDH (Smith et al., 1987), IL-2, IFN-, IL-4, and IL-10
(Villinger et al., 1995) have been published elsewhere.
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